- Home
- Publications
- Publication Search
- Publication Details
Title
Toll‐like receptors: A pathway alluding to cancer control
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-05-30
DOI
10.1002/jcp.28879
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-κB signaling pathways
- (2018) You Dong Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Functional Toll-like Receptor 4 Overexpression in Papillary Thyroid Cancer by MAPK/ERK–Induced ETS1 Transcriptional Activity
- (2018) Victoria Peyret et al. MOLECULAR CANCER RESEARCH
- Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness
- (2017) Marit Bugge et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy
- (2017) V Mett et al. ONCOGENE
- High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients
- (2017) Joni Leppänen et al. VIRCHOWS ARCHIV
- Toll-like receptor-4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women
- (2017) Abdelhabib Semlali et al. OncoTargets and Therapy
- Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth
- (2017) Johanna C. Klein et al. Nature Communications
- Toll-like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer
- (2017) Radhashree Maitra et al. Oncotarget
- Fucoidan induces Toll-like receptor 4-regulated reactive oxygen species and promotes endoplasmic reticulum stress-mediated apoptosis in lung cancer
- (2017) Hsien-Yeh Hsu et al. Scientific Reports
- Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade
- (2017) Jorrit De Waele et al. OncoImmunology
- Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans
- (2017) Madison R. Chandler et al. PLoS One
- Modulation of Toll-like receptor signaling in innate immunity by natural products
- (2016) Luxi Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Elie Metchnikoff, the Man and the Myth
- (2016) Siamon Gordon Journal of Innate Immunity
- Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+T-cell axis
- (2016) Craig M. Brackett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells
- (2016) Mathieu Veyrat et al. Oncotarget
- Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett’s esophagus, dysplasia and adenocarcinoma
- (2016) Heikki Huhta et al. Oncotarget
- TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration
- (2016) Anthony L. Schwartz et al. Oncotarget
- Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo
- (2016) Jouko Sandholm et al. Oncotarget
- Combining vasculature disrupting agent and toll-like receptor 7/8 agonist for cancer therapy
- (2016) Anushree Seth et al. Oncotarget
- The role of Toll-like receptor 9 in gynecologic cancer
- (2016) E. Fehri et al. Current Research in Translational Medicine
- The Role of TLR4 in Chemotherapy-Driven Metastasis
- (2015) S. Ran CANCER RESEARCH
- TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients
- (2015) D. M. S. Hossain et al. CLINICAL CANCER RESEARCH
- Toll-like receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model
- (2015) TAO YIN et al. Molecular Medicine Reports
- The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism
- (2015) Hua Yang et al. Oncotarget
- TLR4/IFNγ pathways induce tumor regression via NOS II-dependent NO and ROS production in murine breast cancer models
- (2015) Myriam Lamrani et al. OncoImmunology
- Astragalus Mongholicus Regulate the Toll-Like-Receptor 4 Meditated Signal Transduction of Dendritic Cells to Restrain Stomach Cancer Cells
- (2014) Y Tian et al. African Journal of Traditional Complementary and Alternative Medicines
- Expression of Toll-like Receptor 9 Increases with Progression of Cervical Neoplasia in Tunisian Women - A Comparative Analysis of Condyloma, Cervical Intraepithelial Neoplasia and Invasive Carcinoma
- (2014) Emna Fehri et al. Asian Pacific Journal of Cancer Prevention
- Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer
- (2014) A Trejo-de la O et al. GENES AND IMMUNITY
- Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis
- (2014) Johanna Korvala et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue
- (2014) Joonas H. Kauppila et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- The mechanism of action of BCG therapy for bladder cancer—a current perspective
- (2014) Gil Redelman-Sidi et al. Nature Reviews Urology
- MAP1S Controls Breast Cancer Cell TLR5 Signaling Pathway and Promotes TLR5 Signaling-based Tumor Suppression
- (2014) Ming Shi et al. PLoS One
- MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma
- (2014) Chen-Tsung Huang et al. Scientific Reports
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Different Toll-Like Receptor Expression Patterns in Progression toward Cancer
- (2014) Lauri Jouhi et al. Frontiers in Immunology
- Beyond MyD88 and TRIF Pathways in Toll-Like Receptor Signaling
- (2014) Vincent Piras et al. Frontiers in Immunology
- Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis
- (2013) V Damiano et al. BRITISH JOURNAL OF CANCER
- Association of TLR2, TLR3, TLR4 and CD14 genes polymorphisms with oral cancer risk and survival
- (2013) K Zeljic et al. ORAL DISEASES
- Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RAR and tumor regression
- (2013) R. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased Toll-like receptor 5 expression indicates esophageal columnar dysplasia
- (2013) Olli Helminen et al. VIRCHOWS ARCHIV
- Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer
- (2013) MARJA-RIITTA VÄISÄNEN et al. Oncology Letters
- Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
- (2012) Johanna Tuomela et al. BREAST CANCER RESEARCH AND TREATMENT
- STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
- (2012) Hazel Tye et al. CANCER CELL
- Activation of Toll-like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth
- (2011) Z. Cai et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma
- (2011) Joonas H Kauppila et al. HISTOPATHOLOGY
- Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma
- (2011) Hanna Ronkainen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Monthly intravesical bacillus Calmette-Guérin maintenance therapy for non-muscle-invasive bladder cancer: 10-year experience in a single institute
- (2011) KOO HAN YOO et al. Experimental and Therapeutic Medicine
- Amplifying TLR-MyD88 Signals within Tumor-Specific T Cells Enhances Antitumor Activity to Suboptimal Levels of Weakly Immunogenic Tumor Antigens
- (2010) D. Geng et al. CANCER RESEARCH
- Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
- (2010) C. Brignole et al. CANCER RESEARCH
- Stimulation of the endosomal TLR pathway enhances autophagy-induced cell death in radiotherapy of breast cancer
- (2010) Su-Jin Kang et al. Genes & Genomics
- TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage
- (2010) F A Carvalho et al. Mucosal Immunology
- Toll-like receptor expression in normal ovary and ovarian tumors
- (2009) Mingfu Zhou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Novel Toll-Like Receptor 9 Agonist Cooperates with Trastuzumab in Trastuzumab-Resistant Breast Tumors through Multiple Mechanisms of Action
- (2009) V. Damiano et al. CLINICAL CANCER RESEARCH
- Phenylmethimazole Decreases Toll-Like Receptor 3 and Noncanonical Wnt5a Expression in Pancreatic Cancer and Melanoma Together with Tumor Cell Growth and Migration
- (2009) A. L. Schwartz et al. CLINICAL CANCER RESEARCH
- Elie Metchnikoff: Father of natural immunity
- (2008) Siamon Gordon EUROPEAN JOURNAL OF IMMUNOLOGY
- Increased expression of Toll-like receptor 5 during progression of cervical neoplasia
- (2007) W.Y. KIM et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search